Home » Topics » Regulatory

Regulatory
RSS

FDA approves first treatment for advanced BCC

Jan. 31, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Indication for Gadovist 1.0 is expanded

Jan. 30, 2012

FDA expands Keppra indication

Jan. 26, 2012

FDA approves gel for actinic keratosis

Jan. 26, 2012

Extended indication for Rebif approved in E.U.

Jan. 25, 2012

FDA approves subcutaneous Velcade

Jan. 24, 2012

FDA approves new pediatric formulations of Viread

Jan. 19, 2012

Abilify approved for new indication in Japan

Jan. 18, 2012

FDA approves new product for methotrexate poisoning due to impaired renal function

Jan. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...